Hackensack Meridian Children’s Health Pediatric Oncology
Offering cutting-edge treatment protocols and hands-on care from newborns to young adults.
Hackensack Meridian Children’s Health pediatric oncologists are leading cutting-edge clinical research while providing diagnosis and treatment of leukemia, lymphoma, neuroblastoma, bone, brain and kidney tumors, as well as rare tumor types.
Joseph M. Sanzari Children’s Hospital Studies New Combination Therapy to Treat Rare, Aggressive Cancer of the Central Nervous System
Hospital is the only site in New Jersey participating in international clinical trial
Joseph M. Sanzari Children’s Hospital Launches Cryopreservation, New Jersey’s Only Fertility Preservation Program
Program offers hope to young patients who undergo cancer treatment that may affect fertility
Research Studies Impact of Chemotherapy-Induced Thrombocytopenia on Pediatric Cancer Treatment
Complication may require platelet transfusions and treatment modifications
New Hematology-Oncology Specialist Joins Joseph M. Sanzari Children’s Hospital
Dr. Camacho-Bydume brings expertise in treatment of blood cancers in children
New Pediatric Hematology-Oncology Specialist to Join Hospital
Dr. Degliuomini’s clinical and research focus is on the effects of children’s cancer treatment on platelets
Pediatric Oncologist/Hematologist Co-Authors Article Accepted for Publication in Leukemia & Lymphoma
Global working group addresses rare subtype of Hodgkin lymphoma
Critical Side Effect Study to Assess the Combination of Trametinib and Everolimus
Treatment offers hope for most common type of brain tumor in children
Hackensack Meridian Children’s Health K. Hovnanian Children’s Hospital to Provide Pediatric Patients Access to Latest Trials for the Treatment of Cancer
Gains Affiliate Status in the Prestigious Children’s Oncology Group (COG)
Joseph M. Sanzari Children’s Hospital Offers New Clinical Trial for Children and Young Adults Diagnosed with Aggressive or Recurrent Brain Tumors
Hospital Among Only a Few in the U.S. to Offer Clinical Trial Through Pacific Pediatric Neuro-Oncology Consortium Membership
CDI Laboratory Secures NIH Funding for Thymus Immunotherapy Research
Zakrzewski Lab Aims to Train Immune System to Make Its Own CAR T-Cells
Joseph M. Sanzari Children’s Hospital Establishes Fertility Preservation Program for Long-Term Pediatric Cancer Survivors
Program aims to prevent or decrease the late effects of chemotherapy, radiation therapy and surgery
Clinical Trial Will Evaluate Combination of Therapies in Pediatric and Young Adult Patients with Recurrent Low Grade Gliomas
Researchers Test Combination Therapy for Common Pediatric Tumors
Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center Joins the Pacific Pediatric Neuro-Oncology Consortium (PNOC)
Worldwide Partnership Develops New Therapies for Brain Tumors in Children and Young Adults, Offers Exclusive Clinical Trial Access
Hackensack Meridian Children's Health Joins with ProCure NJ to Offer Advanced Proton Therapy for Cancer
Advanced Radiation Therapy Is Now Available for Patients at Hackensack Meridian Children’s Health
Pediatric Cancer Trial of Optune Device at Hackensack Meridian Children’s Health
Phase 1 Clinical Trial Tests TTFields Device When Combined with Chemotherapy for Pediatric Patients with Glioblastoma Multiforme
Hackensack Meridian Health Opens Pediatric Neuro-Oncology Laboratory at the Center for Discovery & Innovation (CDI)
First Lab of Its Kind in New Jersey to Focus on Pediatric Brain Tumor Research
K. Hovnanian Children’s Hospital First in U.S. Granted Children’s Oncology Group (COG) Affiliate Status
Opens Opportunities for Pediatric Patients to Enroll in the Latest Cancer Treatment Trials